Among patients with ER-positive ABC, 51 patients (51/99: 51.5%) in the shorter TTF group and 68 patients (68/112: 60.7%) in the longer TTF group received endocrine therapy for advanced breast cancer treatment before 1LCT. The gene discussed is ESR1; the disease is breast cancer.